×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Oric Pharmaceuticals Financial Statements 2018-2025 | ORIC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data | Millions of US $ except per share data
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Revenue
-
-
-
-
-
-
-
Cost Of Goods Sold
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
Research And Development Expenses
$114.072
$85.172
$66.68
$56.858
$60.764
$22.844
$19.026
SG&A Expenses
$28.823
$25.608
$25.087
$22.013
$13.422
$5.725
$3.345
Other Operating Income Or Expenses
-
-
-
-
-
-
-
Operating Expenses
-
-
-
-
-
-
-
Operating Income
$-142.895
$-110.78
$-91.767
$-78.871
$-74.186
$-28.569
$-22.371
Total Non-Operating Income/Expense
$15.048
$10.083
$2.645
$0.156
$0.483
$1.686
$1.008
Pre-Tax Income
$-127.847
$-100.697
$-89.122
$-78.715
$-73.703
$-26.883
$-21.363
Income Taxes
-
-
-
-
-
-
-
Income After Taxes
$-127.847
$-100.697
$-89.122
$-78.715
$-73.703
$-26.883
$-21.363
Other Income
-
-
-
-
-
-
-
Income From Continuous Operations
$-127.847
$-100.697
$-89.122
$-78.715
$-73.703
$-26.883
$-21.363
Income From Discontinued Operations
-
-
-
-
-
-
-
Net Income
$-127.847
$-100.697
$-89.122
$-78.715
$-73.703
$-26.883
$-21.363
EBITDA
$-149.891
$-115.917
$-91.843
$-76.625
$-72.917
$-27.541
$-21.468
EBIT
$-142.895
$-110.78
$-91.767
$-78.871
$-74.186
$-28.569
$-22.371
Basic Shares Outstanding
70
51
40
38
22
2
2
Shares Outstanding
70
51
40
38
22
2
2
Basic EPS
$-1.83
$-1.96
$-2.25
$-2.07
$-3.36
$-14.15
$-12.32
EPS - Earnings Per Share
$-1.83
$-1.96
$-2.25
$-2.07
$-3.36
$-14.15
$-12.32
www.jqwidgets.com